Nav: Home

Allina Health presents LifeCourse developments at national conference

June 15, 2016

MINNEAPOLIS - (June 15, 2016) - For many health care professionals, emphasizing quality of life over clinical outcomes is new ground. Allina Health will present three ground-breaking findings at the AcademyHealth 2016 Annual Research Meeting this month in Boston. All are based on LifeCourse, a multi-year study of a whole-person approach to late-life care.

Evaluating Quality of Life: Whole Person Intervention for Late Life Patients with Chronic Illness compared 190 heart failure, cancer, and dementia patients participating in the LifeCourse intervention with 157 patients receiving usual care. Quality of life scores for the study patients were significantly better than for the other patients after six months.

"As traditional healthcare models serve patients with acute needs approaching the end of life, the individual preferences and support needs of patients with complex chronic illness are often underserved. Quality of life indicators enable understanding of healthcare delivery beyond system oriented outcomes, shedding light on the effect of holistic support care for those living with complex chronic illness in late life," said Tetyana Shippee, MS, PhD, Assistant Professor of Health Policy & Management at the University of Minnesota.

Development and Validation of a New Patient-Centered Experience Tool in Patients with Serious Illness included 770 patients who were not yet eligible for hospice but sick enough to receive benefits of a supportive care approach two to three years prior to death.

Researchers said existing experience measures were not particularly useful in understanding or supporting patients with serious illness in later life. They developed a tool that asked patients to rate 30 items on a four-point scale ten different domains related to patient experience with care, such as repeat myself, goals, and trust.

"Our patient-centered experience scale is highly reliable and can be used to better understand the needs of complex patients and streamline their care," said Karl Fernstrom, MPH, Manager in Applied Research at Allina Health.

Repeated Group Interviews: Supporting and Empowering Staff during Transformation studied a support system for LifeCourse staff. Eighteen team members participated, including nurses, social workers, a pharmacist, a chaplain, a marriage and family therapist, and trained lay care professionals called care guides.

"Health care staff members who participate in innovative care delivery may face challenges stemming from resistance to the innovation and lack of clarity about the future," said Cindy Cain, MA, PhD.

Initially, group interviews with staff seemed to help them solve problems, strategize about the future, leverage resources, and learn from others. Meetings became less frequent as confidentiality became a concern with some staff. This study continues as researchers look for "additional procedures necessary for protecting the psychological safety of staff members," Cain said.
-end-
More about Allina Health LifeCourse

LifeCourse is a late life supportive care approach employing lay healthcare workers called care guides who collaborate with care teams and community resources to help patients and their key friends and family navigate the complexities of serious illness. LifeCourse aims to maintain or improve quality of life and care experience and improve service utilization. For more information on LifeCourse, visit lifecoursemn.org.

Allina Health is dedicated to the prevention and treatment of illness and enhancing the greater health of individuals, families and communities throughout Minnesota and Western Wisconsin. A not-for-profit health care system, Allina Health cares for patients from beginning to end-of-life through its 90+ clinics, 13 hospitals, 15 retail pharmacies, specialty care centers and specialty medical services, home care, senior transitions, hospice care, home oxygen and medical equipment and emergency medical transportation services.

For more information, visit us at allinahealth.org, Facebook, Twitter, YouTube or Healthy Set Go.

Allina Health

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...